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Supplementary Figure 1. Sanger sequencing of insert region from pNL2.2 Ifng +18k reporter 
vector. Chromatogram of the pNL2.2 Ifng +18k reporter vector insert containing a 3x concatenated 
sequence with a TPA-response element (TRE) embedded motif from the Ifng +18k enhancer region.   
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Supplementary Figure 2. Sanger sequencing of insert region of pcDNA4-BACH2 inducible 
vector. a, and b,  Sequence assembly of human BACH2 cDNA subcloned into pcDNA4 vector data. a, 
Representation of primer walk strategy followed for insert sequencing. b, Chromatogram showing 
pcDNA4-BACH2 inducible vector insert sequence after data analysis.  
Supplementary Figure 3. Specific induction of BACH2 protein expression upon tetracycline 
treatment of the BACH2 reporter line. Western blot of total protein lysates with or without tetracycline 
pre-treatment. The specificity of the BACH2 signal was confirmed by pre-incubating the primary anti-
BACH2 antibody with an anti-BACH2 blocking peptide prior to primary antibody staining.  
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Supplementary Figure 4. Signal-driven luciferase expression of inducible-BACH2 reporter 
cells pre-treated with titrated tetracycline doses. Signal-driven luminescence of inducible-
BACH2 reporter cells at given tetracycline concentrations following stimulation with PMA/ionomycin 
showing minimal luminescence at 1 μg/ml tetracycline. Data show 4 culture replicates per condition. 
Bars and error represent mean (SD). 
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Supplementary Figure 5. Association signal-driven luciferase expression and tetracycline 
dose in the BACH2 reporter cell line. Signal-driven luminescence of inducible-BACH2 reporter 
cells at given tetracycline concentrations following stimulation with PMA/ionomycin. Data are 
representative of 2 independently repeated experiments with 3 culture replicates per condition. Bars 
and error represent mean (SD). 
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Supplementary Figure 6. Schematic representation of the proposed function of BACH2 in 
the developed reporter assay.  
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